Article

Higher cataract risk connected to statin use

An increased risk of cataracts appears to be associated with the use of cholesterol-lowering statins, according to a September report published by JAMA Ophthalmology.

 

Chicago-An increased risk of cataracts appears to be associated with the use of cholesterol-lowering statins, according to a September report published by JAMA Ophthalmology.

Jessica Leuschen, MD, of the San Antonio Military Medical Center, Texas, and colleagues analyzed data from a military health-care system from Oct. 2011 to March 2010 for the report. Their analysis matched 6,972 pairs of statin users and non-users.

In the report’s primary analysis, the risk of cataract was higher among statin users compared with non-users-a finding that held up when accounting for other factors that could explain the result (odds ratio, 1.27).

The authors of the report noted that prior studies of the association between statins and cataracts have yielded different results, with some suggesting an increased risk and others find no, or inconsistent, associations.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.